A recent feature article in Nature examined the scientific impact of nations using the metrics of total publications and citations.1 For decision-making purposes, the article appears to be misleading, because critical and noncritical technologies, with high-tech and low-tech components, are country-aggregated in these numbers. Most important for potential users are critical technologies that impact strongly defense and civilian commerce.For example, in the 1997–2001 time frame, China is li
A recent feature article in
For example, in the 1997–2001 time frame, China is listed as ninth in numbers of total publications1 and does not even show up on the footprint charts in the article. Yet a search of the
China ranks first, 14% higher than the United States in this crucial technology. In the top six countries, the ...
When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.
Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST
Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.
